ANTX AN2 Therapeutics Inc: Multiplikator nilai perusahaan marang pendapatan

The EV/Sales valuation demonstrates historical business value ranges, with the metric currently fixed at 0.00. The financial stability of AN2 Therapeutics, Inc. (ANTX) is based on substantial grants and liquid assets without credit encumbrances. Global growth potential is driven by the scaling of unique formulas at a low cost of production. Innovations are implemented through robotic molecule screening and automated research data analysis.
ANTX (AN2 Therapeutics Inc): rincian analitis lan laporan miturut indikator

This ratio determines the market value of the business, including net debt, per unit of revenue, eliminating the impact of capital structure on the valuation. By analyzing changes in the EV/Sales multiple, an investor can see how the market values the potential for developing antibiotics against rare pulmonary infections relative to the current revenues of AN2 Therapeutics (ANTX) against the backdrop of clinical trial costs.